Cargando…
Dynamic pathology of islet endocrine cells in type 2 diabetes: β‐Cell growth, death, regeneration and their clinical implications
Diabetes is defined as a disease of hyperglycemic metabolic disorder caused by impaired insulin action or low insulin secretion, resulting in the occurrence of vascular complications. Based on this definition, diabetes therapy has long been oriented to correct hyperglycemia against the specific comp...
Autores principales: | Yagihashi, Soroku, Inaba, Wataru, Mizukami, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773678/ https://www.ncbi.nlm.nih.gov/pubmed/27042265 http://dx.doi.org/10.1111/jdi.12424 |
Ejemplares similares
-
Age‐associated changes of islet endocrine cells and the effects of body mass index in Japanese
por: Mizukami, Hiroki, et al.
Publicado: (2014) -
Quo vadis: Where have the β-cells gone?
por: Yagihashi, Soroku, et al.
Publicado: (2015) -
Augmented reduction of islet β‐cell mass in Goto‐Kakizaki rats fed high‐fat diet and its suppression by pitavastatin treatment
por: Mizukami, Hiroki, et al.
Publicado: (2012) -
Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients
por: Kamata, Kosuke, et al.
Publicado: (2014) -
Exploring a New Therapy for Diabetic Polyneuropathy – The Application of Stem Cell Transplantation
por: Mizukami, Hiroki, et al.
Publicado: (2014)